VEGF inhibitors for macular degeneration not tied to stroke

NEW YORK (Reuters Health) - Vascular endothelial growth factor (VEGF) inhibitors used for age-related macular degeneration did not increase patients' risk of stroke in a population-based study in Canada.

Full Story →